Pharma Journalist -

UCB, a global biopharmaceutical company, and Aitia, a leader in the application of Causal AI and “Digital Twins” to discover and develop new drugs, announced an early drug discovery…
Read More...

With only 5 weeks to go, the 80+ attendee list for the upcoming mRNA Process Development and Manufacturing Summit Europe (April 18th – 20th | Frankfurt, Germany) is still growing fast,…
Read More...

GSK plc announced that the China National Medical Products Administration has accepted for review a new drug application for Nucala (mepolizumab) as an add-on maintenance treatment for…
Read More...

AcelRx Pharmaceuticals, Inc. announced the divestment of its FDA-approved drug, DSUVIA to Alora Pharmaceuticals (Alora).  The agreement allows AcelRx to participate in the long-term…
Read More...

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to provide a single booster dose of the companies’…
Read More...

Cingulate Inc., a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a pipeline of next-generation…
Read More...

Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D),…
Read More...

Pfizer Inc. and Seagen Inc. announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers,…
Read More...

Cytovance Biologics, Inc. (Cytovance Biologics), a biopharmaceutical contract development and manufacturing organization (CDMO), and Phenotypeca Limited (Phenotypeca), a research and…
Read More...

Cancer Research UK and UCB announced a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates through clinical trials. The…
Read More...